Key Financial’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Key Financial's REGN Position: Q3 2026 in Review
Key Financial reduced its Regeneron Pharmaceuticals (REGN) stake by 15% in Q3 2026, selling an estimated $23.4K and leaving 179 shares worth $136K. The position accounts for 0.02% of the portfolio, ranked #361.
Key Financial first reported a position in REGN in Q1 2020 and has held it in 21 quarters since. The position peaked at $323K in Q3 2024. 1,212 funds tracked by Wall St. Rank hold REGN as of Q3 2026.
- Key Financial held 179 shares of Regeneron Pharmaceuticals worth $136K as of Q3 2026.
- Key Financial sold 31 Regeneron Pharmaceuticals shares in Q3 2026, an estimated $23.4K.
- Regeneron Pharmaceuticals made up 0.02% of Key Financial's portfolio in Q3 2026, its #361 holding.
- Key Financial first reported a position in Regeneron Pharmaceuticals in Q1 2020 and has held it in 21 quarters since.
- Key Financial's Regeneron Pharmaceuticals position peaked at $323K in Q3 2024.
- 1,212 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.
Based on Key Financial's 13F filing for Q3 2026, filed 2 Nov 2026.